Endothelial NO synthase as a source of NO and superoxide Ulrich Förstermann Review Article 26 November 2005 Pages: 5 - 12
Oxidant stress—a major cause of reduced endothelial nitric oxide availability in cardiovascular disease Ulf LandmesserDavid G. HarrisonHelmut Drexler Review Article 12 October 2005 Pages: 13 - 19
Antioxidants and endothelial nitric oxide synthesis Regine HellerGabriele Werner-FelmayerErnst R. Werner Review Article 11 November 2005 Pages: 21 - 28
Growth hormone regulates vascular function—what we know from bench and bedside Thomas ThumJohann Bauersachs Review Article 13 October 2005 Pages: 29 - 32
The synthesis and metabolism of asymmetric dimethylarginine (ADMA) James M. LeiperPatrick Vallance Review Article 08 November 2005 Pages: 33 - 38
Effects of asymmetric dimethylarginine (ADMA) infusion in humans Jan T. KielsteinDimitrios TsikasDanilo Fliser Review Article 14 October 2005 Pages: 39 - 44
Asymmetric dimethylarginine (ADMA) and the risk for coronary heart disease: the multicenter CARDIAC study Henrike LenzenDimitrios TsikasRainer H. Böger Review Article 08 November 2005 Pages: 45 - 49
Circulating and excretory nitrite and nitrate as indicators of nitric oxide synthesis in humans: methods of analysis Dimitrios TsikasFrank-Mathias GutzkiDirk O. Stichtenoth Review Article 12 October 2005 Pages: 51 - 59
Measurement of asymmetric dimethylarginine (ADMA) in human plasma: from liquid chromatography estimation to liquid chromatography-mass spectrometry quantification Jens Martens-LobenhofferStefanie M. Bode-Böger Review Article 11 October 2005 Pages: 61 - 68
The role of nitric oxide in early atherosclerosis Marietta CharakidaJohn E. DeanfieldJulian P. J. Halcox Review Article 08 November 2005 Pages: 69 - 78
Cardiac allograft endothelial dysfunction Sieglinde KoflerParaskevi PetrakopoulouMichael Weis Review Article 12 October 2005 Pages: 79 - 82
Nitric oxide synthase gene transfer and treatment of restenosis: from bench to bedside Heiko E. von der LeyenNancy Chew Review Article 21 October 2005 Pages: 83 - 89
Effect of L-arginine supplementation on NO production in man Stefanie M. Bode-Böger Review Article 29 November 2005 Pages: 91 - 99
Nitric oxide in coronary artery disease: effects of antioxidants Dimitris TousoulisCharalambos AntoniadesChristodoulos Stefanadis Review Article 11 October 2005 Pages: 101 - 107
Relation between β-adrenoceptor stimulation and nitric oxide synthesis in vascular control James M. RitterAlbert FerroPhilip J. Chowienczyk Review Article 08 November 2005 Pages: 109 - 113
Asymmetric dimethylarginine (ADMA): an endogenous inhibitor of angiogenesis John P. Cooke Review Article 29 October 2005 Pages: 115 - 121
Nitric oxide deficiency in chronic renal disease Chris Baylis Review Article 26 October 2005 Pages: 123 - 130
Asymmetric dimethylarginine (ADMA) as a cardiovascular risk factor in end-stage renal disease (ESRD) Carmine ZoccaliFrancesca MallamaciGiovanni Tripepi Review Article 22 September 2005 Pages: 131 - 135
Nitric oxide and endothelial cell aging Judith Haendeler Review Article 12 October 2005 Pages: 137 - 140
Growth hormone, vascular reactivity, and heart failure Raffaele Napoli Review Article 12 October 2005 Pages: 141 - 144
Nitric oxide-donating aspirin (NCX 4016): an overview of its pharmacological properties and clinical perspectives Manlio BollaStefania MomiPiero Del Soldato Review Article 26 November 2005 Pages: 145 - 154